Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study

L. Kappos, R. Gold, D. H. Miller, D.G. MacManus, E. Havrdova, V. Limmroth, C.H. Polman, K. Schmierer, T.A. Yousry, M. Eraksoy, E. Meluzinova, M. Dufek, M.H. Yang, K. Dawson, G.N. O'Neill

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)314-321
JournalMultiple Sclerosis
Volume18
Issue number3
DOIs
Publication statusPublished - 2012

Cite this